The USPTO recognized Harvard innovations in treating diabetes, nanopore-based DNA encoding, NQR spectroscopy, diagnosis of prostate cancer, conditioning for stem cell transplantation, and much more

The USPTO recognized Harvard innovations in soft robotics, antifungals, sub-diffraction-limit imaging, nanopore sensing, optogenetics, and much more

Innovations in enrichment of cells, fluorination of organic compounds, fabrication of nanopores, differentiation of stem cells, soft robotics, and more

Innovations in anti-inflammatory agents, microbiotic treatments, tools for assessing gestational diabetes, optically active structures, vaccine nanotechnology, and more